Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130) (Trehalose free)

Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130) (S1N-M13A1) is a chimeric monoclonal antibody recombinantly expressed in HEK293 cells, which combines the variable regions of a mouse monoclonal antibody with human IgG1 constant domains. The variable regions was obtained from a mouse immunized with purified recombinant SARS-CoV-2 Spike S1 Protein.

Recombinant Monoclonal

AM130

Human IgG1, Kappa

Mouse

Virus

This product can recognize SARS-CoV-2 and SARS-CoV Spike protein RBD domain. No cross-reactivity is detected with Spike protein RBD domain of other coronaviruses, including MERS-CoV, HCoV-229E, HCoV-NL63, HCoV-OC43 and HCoV-HKU1.

* Recommended dilutions are for reference only. Optimal working concentrations may vary depending on your consumables, reagents, and assay conditions. We recommend optimizing for your specific system. No warranty is made regarding performance at any specific dilution.

Protein A purified.

Less than 10%, as determined by SEC-MALS.

Please refer to the Certificate of Analysis (CoA).

Liquid

Supplied a 0.22 μm-filtered solution in PBS (pH 7.4).

Please contact us for customized product forms or formulations.

Please avoid repeated freeze-thaw cycles.

• For long term storage, the product is stable for up to 3 years at -70°C from date of receipt;
• For short term storage, the product is stable for up to 12 months at 2-8°C from date of receipt.

Product Specific Notices: For research use only.